RankingsPricing
  1. US-listed companies
  2. RESMED INC
  3. Financials
  4. Revenue growth (%)

RESMED INCRMD

Market cap
$36.7B
P/E ratio
SummaryFinancials
Period EndRevenue growth (%) YoY (%)
Jun 30, 20259.8-10.14%
Jun 30, 202411-39.23%
Jun 30, 202318+51.05%
Jun 30, 202211.9+47.10%
Jun 30, 20218.1-39.66%
Jun 30, 202013.4+18.10%
Jun 30, 201911.4-13.98%
Jun 30, 201813.2+6.69%
Jun 30, 201712.4+30.25%
Jun 30, 20169.5+19.45%
Jun 30, 20158+197.39%
Jun 30, 20142.7-74.86%
Jun 30, 201310.7+5.75%
Jun 30, 201210.1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)